VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Recent advances in feature selection methods for breast cancer recurrence prediction: A systematic review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...
Under real-world haze conditions, the captured images not only suffer from the haze but also are affected by the noise, which significantly deteriorates the visibility of images. However, most of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results